Community-Pharmacy Clinical-Service Architect

The mandate

The group has piloted vaccinations, point-of-care screening and minor-ailment consultations, but each region has improvised booking rules, consultation space, pharmacist cover, records and referral follow-up. Retail teams celebrate appointment volume while stores cancel at short notice or leave unresolved clinical escalations outside normal workflow. The defined problem is to design one operational model for authorised pharmacy services that protects professional independence and makes demand, capacity, patient journey and outcome visible.

The principal deliverable is a community-pharmacy clinical-service blueprint covering service qualification, consent, booking, pharmacist eligibility, protected consultation flow, stock and cold chain, clinical documentation, escalation, referral, follow-up, reimbursement, incident review and service suspension. It will include store archetypes, capacity logic, role boundaries, minimum data, scheduling rules, quality evidence, exception playbooks, economics and a staged regional deployment plan for three initial service lines.

Four milestones govern the assignment. By week three, milestone one reconstructs thirty patient journeys across six pharmacies and reconciles cancellations, duration, referrals and reimbursement. Week seven produces store archetypes, demand scenarios and alternative service models. Week twelve concludes simulations for staff absence, cold-chain concern, adverse event, digital outage and urgent referral. At week sixteen, the final milestone supplies the approved blueprint, pharmacy readiness pack, workforce model, investment case and rollout decision.

Acceptance rests jointly with the chief operating officer and Clinical Governance Committee, with accountable pharmacists and counsel approving professional and jurisdictional boundaries. Work is accepted only when two regions can schedule, run and close simulated services using the design; every clinical exception reaches a licensed decision maker; capacity protects dispensing obligations; records reconcile without retail-system workarounds; and the committee confirms that no commercial measure rewards inappropriate eligibility or incomplete referral.

The client provides de-identified journey records, service protocols, rosters, competency evidence, store layouts, stock logs, incidents, reimbursement rules, technology interfaces and access to six pharmacies. Consultants will not deliver care, determine eligibility, interpret a clinical result, prescribe, vaccinate, certify premises or operate live services. Medical protocols, payer negotiation, platform engineering and workforce implementation are excluded; unavailable clinical evidence will remain an explicit deployment condition.

Why this is external work

Store operations, retail, digital and clinical leaders each hold part of the service, and internal pilots rewarded local ingenuity rather than comparable evidence. The group has not scaled professional care across heterogeneous sites while preserving dispensing capacity. External architecture brings multi-site clinical-service design and neutral challenge, leaving every patient and professional decision with licensed and accountable leaders.

What you will own

• Reconstruct thirty patient journeys from discovery and booking through consultation, referral, follow-up, reimbursement and closure.
• Segment pharmacies by consultation space, staffing, dispensing load, demand, stock support and local referral access.
• Define decision rights among pharmacists, store leaders, regional operations, digital, clinical governance and external providers.
• Build capacity rules that protect dispensing, breaks, urgent demand, documentation and safe service suspension.
• Test the design against absence, cold-chain concern, adverse event, outage and urgent-referral scenarios.
• Specify readiness evidence, quality sampling, incident learning, commercial safeguards and regional escalation clocks.
• Deliver the approved blueprint, readiness pack, investment case and staged deployment backlog for three services.

Candidate qualifications

• Has designed or scaled regulated community-pharmacy, ambulatory or primary-care services across heterogeneous sites.
• Can evidence a service-volume target changed because pharmacist capacity or referral closure created patient risk.
• Understands booking, consent, competency, consultation flow, cold chain, documentation, reimbursement and clinical escalation.
• Has separated professional decision rights from retail management while creating accountable operational measures.
• Can model site readiness and service capacity without treating every pharmacy or appointment as equivalent.
• Has facilitated licensed professionals, operations, digital and commercial leaders through an acceptance-tested service design.

Non-negotiables

• Can complete six French pharmacy observations and two regional simulations during the four-month engagement.
• Will not deliver care, interpret results, determine eligibility or certify clinical compliance through this assignment.
• Brings direct regulated care-service architecture; retail format or booking-platform work alone is insufficient.
• Will show cancelled, referred and unresolved journeys in performance evidence rather than volume-only reporting.

1. 49 words maximum. Which hidden capacity constraint most often destabilises a new community-pharmacy clinical service?
2. 49 words maximum. Describe a service-suspension trigger you designed that frontline pharmacists could use without commercial permission.
3. 49 words maximum. What patient-journey evidence would prevent a regional rollout despite high appointment demand?